Given our previous demonstration that EGCG suppresses inflammation by modulating the TXNIP/NLRP3/IL‐1β axis in vitro, we hypothesized that EGCG might similarly reduce inflammation in DKD mice through this pathway. This evidence concerns the gene NLRP3 and diabetic kidney disease.